BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8195227)

  • 1. Mutagenic alteration of the distal switch II region of RAS blocks CDC25-dependent signaling functions.
    Mirisola MG; Seidita G; Verrotti AC; Di Blasi F; Fasano O
    J Biol Chem; 1994 Jun; 269(22):15740-8. PubMed ID: 8195227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Saccharomyces cerevisiae CDC25 gene product binds specifically to catalytically inactive ras proteins in vivo.
    Munder T; Fürst P
    Mol Cell Biol; 1992 May; 12(5):2091-9. PubMed ID: 1569942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the Saccharomyces cerevisiae CDC25 gene product and mammalian ras.
    Segal M; Marbach I; Engelberg D; Simchen G; Levitzki A
    J Biol Chem; 1992 Nov; 267(32):22747-51. PubMed ID: 1429624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reconstitution of cdc25 regulated S. cerevisiae adenylyl cyclase and its kinetic properties.
    Engelberg D; Simchen G; Levitzki A
    EMBO J; 1990 Mar; 9(3):641-51. PubMed ID: 2155776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator.
    Martegani E; Vanoni M; Zippel R; Coccetti P; Brambilla R; Ferrari C; Sturani E; Alberghina L
    EMBO J; 1992 Jun; 11(6):2151-7. PubMed ID: 1376246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction between Saccharomyces cerevisiae CDC25 and RAS2 proteins.
    Baroni MD; Marconi G; Parrini MC; Monti P; Alberghina L
    Biochem Biophys Res Commun; 1992 Jul; 186(1):467-74. PubMed ID: 1632785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins.
    Jacquet E; Vanoni M; Ferrari C; Alberghina L; Martegani E; Parmeggiani A
    J Biol Chem; 1992 Dec; 267(34):24181-3. PubMed ID: 1447167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal part of the CDC25 gene product plays a key role in signal transduction in the glucose-induced modulation of cAMP level in Saccharomyces cerevisiae.
    Van Aelst L; Boy-Marcotte E; Camonis JH; Thevelein JM; Jacquet M
    Eur J Biochem; 1990 Nov; 193(3):675-80. PubMed ID: 2174363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of the catalytic domain of CDC25, a Saccharomyces cerevisiae GDP/GTP exchange factor: comparison of its activity on full-length and C-terminal truncated RAS2 proteins.
    Jacquet E; Parrini MC; Bernardi A; Martegani E; Parmeggiani A
    Biochem Biophys Res Commun; 1994 Mar; 199(2):497-503. PubMed ID: 8135791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal part of the CDC25 gene product has Ras-nucleotide exchange activity when present in a chimeric SDC25-CDC25 protein.
    Boy-Marcotte E; Buu A; Soustelle C; Poullet P; Parmeggiani A; Jacquet M
    Curr Genet; 1993; 23(5-6):397-401. PubMed ID: 8319295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucose-induced polyphosphoinositides turnover in Saccharomyces cerevisiae is not dependent on the CDC25-RAS mediated signal transduction pathway.
    Frascotti G; Baroni D; Martegani E
    FEBS Lett; 1990 Nov; 274(1-2):19-22. PubMed ID: 2174802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different kinetic properties of the two mutants, RAS2Ile152 and RAS2Val19, that suppress the CDC25 requirement in RAS/adenylate cyclase pathway in Saccharomyces cerevisiae.
    Créchet JB; Poullet P; Camonis J; Jacquet M; Parmeggiani A
    J Biol Chem; 1990 Jan; 265(3):1563-8. PubMed ID: 2104846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the S. cerevisiae Cdc25 in response to glucose results in its dissociation from Ras.
    Gross E; Goldberg D; Levitzki A
    Nature; 1992 Dec 24-31; 360(6406):762-5. PubMed ID: 1334534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In yeast, RAS proteins are controlling elements of adenylate cyclase.
    Toda T; Uno I; Ishikawa T; Powers S; Kataoka T; Broek D; Cameron S; Broach J; Matsumoto K; Wigler M
    Cell; 1985 Jan; 40(1):27-36. PubMed ID: 2981630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues crucial for Ras interaction with GDP-GTP exchangers.
    Segal M; Willumsen BM; Levitzki A
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5564-8. PubMed ID: 8516302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway.
    Broek D; Toda T; Michaeli T; Levin L; Birchmeier C; Zoller M; Powers S; Wigler M
    Cell; 1987 Mar; 48(5):789-99. PubMed ID: 3545497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDC25, a CDC25-like gene which contains a RAS-activating domain and is a dispensable gene of Saccharomyces cerevisiae.
    Damak F; Boy-Marcotte E; Le-Roscouet D; Guilbaud R; Jacquet M
    Mol Cell Biol; 1991 Jan; 11(1):202-12. PubMed ID: 1986220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Cdc25 antibodies inhibit guanyl nucleotide-dependent adenylyl cyclase of Saccharomyces cerevisiae and cross-react with a 150-kilodalton mammalian protein.
    Gross E; Marbach I; Engelberg D; Segal M; Simchen G; Levitzki A
    Mol Cell Biol; 1992 Jun; 12(6):2653-61. PubMed ID: 1588963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overexpression of the 3' terminal region of the CDC25 gene of Saccharomyces cerevisiae causes growth inhibition and alteration of purine nucleotides pools.
    Frascotti G; Coccetti P; Vanoni MA; Alberghina L; Martegani E
    Biochim Biophys Acta; 1991 Jun; 1089(2):206-12. PubMed ID: 1647210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel, activated RAS mutations alter protein-protein interactions.
    Dalley BK; Cannon JF
    Oncogene; 1996 Sep; 13(6):1209-20. PubMed ID: 8808695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.